PMID- 20637638 OWN - NLM STAT- MEDLINE DCOM- 20101206 LR - 20220410 IS - 1464-3391 (Electronic) IS - 0968-0896 (Print) IS - 0968-0896 (Linking) VI - 18 IP - 16 DP - 2010 Aug 15 TI - The marine sponge metabolite mycothiazole: a novel prototype mitochondrial complex I inhibitor. PG - 5988-94 LID - 10.1016/j.bmc.2010.06.072 [doi] AB - A natural product chemistry-based approach was applied to discover small-molecule inhibitors of hypoxia-inducible factor-1 (HIF-1). A Petrosaspongia mycofijiensis marine sponge extract yielded mycothiazole (1), a solid tumor selective compound with no known mechanism for its cell line-dependent cytotoxic activity. Compound 1 inhibited hypoxic HIF-1 signaling in tumor cells (IC(50) 1nM) that correlated with the suppression of hypoxia-stimulated tumor angiogenesis in vitro. However, 1 exhibited pronounced neurotoxicity in vitro. Mechanistic studies revealed that 1 selectively suppresses mitochondrial respiration at complex I (NADH-ubiquinone oxidoreductase). Unlike rotenone, MPP(+), annonaceous acetogenins, piericidin A, and other complex I inhibitors, mycothiazole is a mixed polyketide/peptide-derived compound with a central thiazole moiety. The exquisite potency and structural novelty of 1 suggest that it may serve as a valuable molecular probe for mitochondrial biology and HIF-mediated hypoxic signaling. CI - Copyright 2010 Elsevier Ltd. All rights reserved. FAU - Morgan, J Brian AU - Morgan JB AD - Department of Pharmacognosy, School of Pharmacy, University of Mississippi, University, MS 38677, USA. FAU - Mahdi, Fakhri AU - Mahdi F FAU - Liu, Yang AU - Liu Y FAU - Coothankandaswamy, Veena AU - Coothankandaswamy V FAU - Jekabsons, Mika B AU - Jekabsons MB FAU - Johnson, Tyler A AU - Johnson TA FAU - Sashidhara, Koneni V AU - Sashidhara KV FAU - Crews, Phillip AU - Crews P FAU - Nagle, Dale G AU - Nagle DG FAU - Zhou, Yu-Dong AU - Zhou YD LA - eng GR - CA047135/CA/NCI NIH HHS/United States GR - R01 CA047135/CA/NCI NIH HHS/United States GR - R01 CA098787-05A2/CA/NCI NIH HHS/United States GR - R01 CA098787-06/CA/NCI NIH HHS/United States GR - C06 RR014503/RR/NCRR NIH HHS/United States GR - CA98787/CA/NCI NIH HHS/United States GR - P20RR021929/RR/NCRR NIH HHS/United States GR - P20 RR021929/RR/NCRR NIH HHS/United States GR - C06 RR-14503-01/RR/NCRR NIH HHS/United States GR - R01 CA098787/CA/NCI NIH HHS/United States GR - R56 CA098787-05A1/CA/NCI NIH HHS/United States GR - R56 CA098787/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20100625 PL - England TA - Bioorg Med Chem JT - Bioorganic & medicinal chemistry JID - 9413298 RN - 0 (Enzyme Inhibitors) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Thiazoles) RN - 0 (mycothiazole) RN - EC 7.1.1.2 (Electron Transport Complex I) SB - IM MH - Animals MH - Cell Line MH - Cell Line, Tumor MH - Cell Survival/drug effects MH - Cells, Cultured MH - Electron Transport Complex I/*antagonists & inhibitors/metabolism MH - Enzyme Inhibitors/isolation & purification/*pharmacology MH - Female MH - Gene Expression Regulation/drug effects MH - Humans MH - Hypoxia-Inducible Factor 1/*antagonists & inhibitors/genetics/metabolism MH - Hypoxia-Inducible Factor 1, alpha Subunit/genetics/metabolism MH - Neovascularization, Pathologic/drug therapy MH - Neurons/drug effects MH - Porifera/*chemistry MH - Rats MH - Thiazoles/isolation & purification/*pharmacology PMC - PMC2918693 MID - NIHMS218547 EDAT- 2010/07/20 06:00 MHDA- 2010/12/14 06:00 PMCR- 2011/08/15 CRDT- 2010/07/20 06:00 PHST- 2010/05/19 00:00 [received] PHST- 2010/06/18 00:00 [revised] PHST- 2010/06/21 00:00 [accepted] PHST- 2010/07/20 06:00 [entrez] PHST- 2010/07/20 06:00 [pubmed] PHST- 2010/12/14 06:00 [medline] PHST- 2011/08/15 00:00 [pmc-release] AID - S0968-0896(10)00600-0 [pii] AID - 10.1016/j.bmc.2010.06.072 [doi] PST - ppublish SO - Bioorg Med Chem. 2010 Aug 15;18(16):5988-94. doi: 10.1016/j.bmc.2010.06.072. Epub 2010 Jun 25.